Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Trientine and Carboplatin in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
- Status
- COMPLETED
- Phase
- PHASE3